Bausch & Lomb (BLCO) EBT Margin (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly EBT Margin came in at 0.79% in Q2 2026, up 1071.0% on a YoY basis from 0.07% in Q2 2025, and up 84.66% quarter-over-quarter from 5.14% in Q1 2026.
Powered by 
Analysis
Bausch & Lomb (BLCO) EBT Margin (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported EBT Margin for 6 consecutive years, with 0.79% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 1071.0% year-over-year to 0.79%; the trailing twelve-month figure through Jun 2026 stood at 1.22% (up 686.0% YoY), and the FY2025 full-year result was 6.21%, down 133.0% from the prior year.
- EBT Margin rose to 0.79% in Q2 2026 per BLCO's latest filing, from 5.14% in the prior quarter.
- Across five years, EBT Margin topped out at 3.26% in Q1 2022 and bottomed at 15.83% in Q1 2025.
- Historically, EBT Margin has averaged 3.38% across 5 years, with a median of 2.66% in 2023.
- The sharpest annual moves came in 2023 and 2026: EBT Margin slumped 917 bps in 2023, then surged 1071 bps in 2026.
- Over 5 years, EBT Margin stood at 0.2% in 2022, then slumped by 2320 bps to 4.86% in 2023, then soared by 84 bps to 0.78% in 2024, then jumped by 218 bps to 0.93% in 2025, then tumbled by 185 bps to 0.79% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 0.79%, 5.14%, and 0.93% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.32% |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | -0.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.79% |
| Mar 31, 2026 | -5.14% |
| Dec 31, 2025 | 0.93% |
| Sep 30, 2025 | -0.23% |
| Jun 30, 2025 | -11.50% |
| Mar 31, 2025 | -15.83% |
| Dec 31, 2024 | -0.78% |
| Sep 30, 2024 | -4.85% |
| Jun 30, 2024 | -6.25% |
| Mar 31, 2024 | -8.19% |
| Dec 31, 2023 | -4.86% |
| Sep 30, 2023 | -3.48% |
| Jun 30, 2023 | -1.84% |
| Mar 31, 2023 | -5.91% |
| Dec 31, 2022 | -0.20% |
| Sep 30, 2022 | 2.02% |
| Jun 30, 2022 | 2.87% |
| Mar 31, 2022 | 3.26% |
| Dec 31, 2021 | 8.59% |
| Sep 30, 2021 | 9.27% |